Manufacturer copay assistance · Givlaari (J0223) · Alnylam Pharmaceuticals
Eligible patients pay $0… · Maximum benefit Annual cap applies — call Alnylam Assist for current dollar amount · Covers Givlaari drug cost — does NOT cover infusion administration
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Givlaari — the program's cap applies against the patient share CareCost calculates.
Yes — Alnylam Assist Commercial Copay Program (Givlaari) from Alnylam Pharmaceuticals. Eligible patients pay $0 out-of-pocket. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay $0 out-of-pocket Maximum benefit: Annual cap applies — call Alnylam Assist for current dollar amount. Covers Givlaari drug cost — does NOT cover infusion administration
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.